Eli Lilly & Co Stock Performance
Eli Lilly & Co’s stock price has experienced fluctuations in recent days. The company’s shares have shown a slight increase, with reports indicating a 2.7% rise following insider buying activity.
Market Comparison The stock’s performance is being compared to the broader market, with the S&P 500 index showing minimal changes.
Price Adjustment Eli Lilly has raised the list price of its diabetes drug Mounjaro in the UK, in response to pressure from US President Donald Trump to align American drug costs with other nations.
Stock Price Stability The company’s stock price remains relatively stable, with some minor variations in the market.
Key Statistics
- Eli Lilly & Co’s stock price has shown a 2.7% rise following insider buying activity
- The S&P 500 index has shown minimal changes
- Eli Lilly has raised the list price of Mounjaro in the UK